Insider Trading activities at Editas Medicine, Inc. (EDIT)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Editas Medicine, Inc. (EDIT) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Editas Medicine, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1650664.

Total stock buying since 2015: $4,697,999.
Total stock sales since 2015: $68,111,615.
Total stock option exercises since 2015: $2,934,980.


25 insiders reported insider trading activities at Editas Medicine, Inc. (EDIT):
Insider trading activities of Mei Baisong
Insider trading activities of Albright Charles
Insider trading activities of O'neill Gilmore Neil
Insider trading activities of Eaton Bruce
Insider trading activities of Bitterman Kevin
Insider trading activities of Shearman Mark S
Insider trading activities of Sundheim Daniel S.
Insider trading activities of Hopfield Jessica
Insider trading activities of Michaels Lisa Anne
Insider trading activities of Bosley Katrine
Insider trading activities of Collins Cynthia
Insider trading activities of Robertson Michelle
Insider trading activities of Glucksmann Alexandra
Insider trading activities of Nikolic Boris
Insider trading activities of Parison Amy
Insider trading activities of Viking Long Fund Master Ltd.
Insider trading activities of Lucera Erick
Insider trading activities of Myer Vickesh
Insider trading activities of Deerfield Mgmt Hif, L.p.
Insider trading activities of Hack Andrew A. F.
Insider trading activities of Mullen James C
Insider trading activities of Polaris Venture Partners Founders' Fund Vi, L.p.
Insider trading activities of Burkly Linda
Insider trading activities of Cox Gerald Frank
Insider trading activities of Starr Kevin P

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Editas Medicine, Inc. (EDIT).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 0 $0 49,665 $95,751 0 $0
2024 45,000 $253,890 155,927 $1,229,909 0 $0
2023 0 $0 23,864 $221,882 0 $0
2022 0 $0 67,615 $1,662,727 0 $0
2021 30,800 $1,420,769 21,277 $970,033 2,500 $76,625
2020 0 $0 74,764 $3,061,148 77,977 $990,600
2019 10,200 $244,188 44,088 $1,061,519 26,895 $140,729
2018 16,700 $630,032 346,082 $11,833,576 180,284 $1,584,070
2017 39,000 $549,120 1,107,980 $19,447,380 49,649 $142,306
2016 100,000 $1,600,000 1,724,948 $28,527,690 1,000 $650
2015 4,081,628 $0 0 $0 0 $0

Table 2. Monthly summary of insider trading at Editas Medicine, Inc. (EDIT).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-09 0 $0 6,760 $17,547 0 $0
2025-08 0 $0 679 $1,751 0 $0
2025-07 0 $0 5,121 $12,756 0 $0
2025-06 0 $0 16,364 $28,210 0 $0
2025-03 0 $0 20,741 $35,487 0 $0
2024-12 0 $0 2,159 $4,483 0 $0
2024-09 0 $0 2,073 $7,099 0 $0
2024-07 0 $0 18,505 $98,832 0 $0
2024-06 0 $0 12,702 $69,809 0 $0
2024-05 45,000 $253,890 22,337 $125,399 0 $0
2024-03 0 $0 98,151 $924,287 0 $0
2023-12 0 $0 103 $1,122 0 $0
2023-11 0 $0 695 $5,705 0 $0
2023-09 0 $0 103 $908 0 $0
2023-08 0 $0 843 $7,214 0 $0
2023-07 0 $0 4,317 $37,989 0 $0
2023-06 0 $0 6,591 $62,633 0 $0
2023-05 0 $0 1,752 $17,245 0 $0
2023-03 0 $0 285 $2,532 0 $0
2023-02 0 $0 7,423 $72,238 0 $0
2023-01 0 $0 1,752 $14,296 0 $0
2022-08 0 $0 293 $5,449 0 $0
2022-06 0 $0 7,795 $82,315 0 $0
2022-05 0 $0 297 $3,894 0 $0

Table 3. Detailed insider trading at Editas Medicine, Inc. (EDIT)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-09-03 Parison Amy (SVP, Chief Financial Officer) Sale 458 2.60 1,188
2025-09-03 Burkly Linda (EVP, CHIEF SCIENTIFIC OFFICER) Sale 710 2.60 1,843
2025-09-03 O'neill Gilmore Neil (CEO) Sale 5,592 2.60 14,516
2025-08-07 Parison Amy (SVP, Chief Financial Officer) Sale 679 2.58 1,751
2025-07-31 Burkly Linda (EVP, CHIEF SCIENTIFIC OFFICER) Sale 5,121 2.49 12,756
2025-06-03 Parison Amy (SVP, Chief Financial Officer) Sale 446 1.72 768
2025-06-03 Burkly Linda (EVP, CHIEF SCIENTIFIC OFFICER) Sale 726 1.72 1,251
2025-06-03 O'neill Gilmore Neil (CEO) Sale 15,192 1.72 26,191
2025-03-04 O'neill Gilmore Neil (CEO) Sale 16,632 1.71 28,457
2025-03-04 Lucera Erick (EVP, CHIEF FINANCIAL OFFICER) Sale 4,109 1.71 7,030
2024-12-03 Mei Baisong (EVP, CHIEF MEDICAL OFFICER) Sale 541 2.08 1,123
2024-12-03 O'neill Gilmore Neil (CEO) Sale 1,618 2.08 3,360
2024-09-04 Mei Baisong (EVP, CHIEF MEDICAL OFFICER) Sale 518 3.42 1,774
2024-09-04 O'neill Gilmore Neil (CEO) Sale 1,555 3.42 5,325
2024-07-25 Burkly Linda (EVP, CHIEF SCIENTIFIC OFFICER) Sale 11,886 5.42 64,374
2024-07-19 Mei Baisong (EVP, CHIEF MEDICAL OFFICER) Sale 6,619 5.21 34,458
2024-06-04 Mei Baisong (EVP, CHIEF MEDICAL OFFICER) Sale 511 5.50 2,808
2024-06-04 O'neill Gilmore Neil (CEO) Sale 12,191 5.50 67,001
2024-05-20 Lucera Erick (EVP, CHIEF FINANCIAL OFFICER) Sale 22,337 5.61 125,399
2024-05-13 Hopfield Jessica Buy 45,000 5.64 253,890
2024-03-05 O'neill Gilmore Neil (CEO) Sale 77,824 9.42 732,868
2024-03-04 Mei Baisong (SVP, CHIEF MEDICAL OFFICER) Sale 20,327 9.42 191,419
2023-12-05 Eaton Bruce (EVP, CBO AND CTO) Sale 103 10.90 1,122
2023-11-14 Eaton Bruce (EVP, CBO AND CTO) Sale 695 8.21 5,705
2023-09-06 Eaton Bruce (EVP, CBO AND CTO) Sale 103 8.82 908
2023-08-11 Eaton Bruce (EVP, CBO AND CTO) Sale 702 8.59 6,032
2023-08-08 Eaton Bruce (EVP, CBO AND CTO) Sale 141 8.39 1,182
2023-07-19 Mei Baisong (SVP, CHIEF MEDICAL OFFICER) Sale 4,317 8.80 37,989
2023-06-05 Eaton Bruce (EVP, CBO AND CTO) Sale 105 9.50 997
2023-06-05 O'neill Gilmore Neil (CEO) Sale 6,486 9.50 61,636
2023-05-11 Eaton Bruce (EVP, CBO AND CTO) Sale 668 9.87 6,594
2023-05-11 Robertson Michelle (EVP, CHIEF FINANCIAL OFFICER) Sale 949 9.87 9,368
2023-05-09 Eaton Bruce (EVP, CBO AND CTO) Sale 135 9.51 1,283
2023-03-03 Eaton Bruce (EVP, CBO AND CTO) Sale 101 8.89 897
2023-03-03 Robertson Michelle (EVP, CHIEF FINANCIAL OFFICER) Sale 184 8.89 1,635
2023-02-13 Robertson Michelle (EVP, CHIEF FINANCIAL OFFICER) Sale 4,287 9.66 41,433
2023-02-13 Shearman Mark S (EVP, CHIEF SCIENTIFIC OFFICER) Sale 2,790 9.66 26,965
2023-02-07 Eaton Bruce (EVP, CBO AND CTO) Sale 346 11.10 3,840
2023-01-10 Robertson Michelle (EVP, CHIEF FINANCIAL OFFICER) Sale 1,752 8.16 14,296
2022-08-09 Eaton Bruce (EVP, CHIEF BUSINESS OFFICER) Sale 293 18.60 5,449
2022-06-15 Shearman Mark S (EVP, CHIEF SCIENTIFIC OFFICER) Sale 5,145 10.06 51,743
2022-06-03 Eaton Bruce (EVP, CHIEF BUSINESS OFFICER) Sale 1,123 11.54 12,956
2022-06-03 Robertson Michelle (EVP, CHIEF FINANCIAL OFFICER) Sale 1,527 11.54 17,616
2022-05-09 Eaton Bruce (EVP, CHIEF BUSINESS OFFICER) Sale 297 13.11 3,894
2022-04-01 Eaton Bruce (EVP, CHIEF BUSINESS OFFICER) Sale 1,258 19.64 24,707
2022-03-03 Eaton Bruce (EVP, CHIEF BUSINESS OFFICER) Sale 403 17.33 6,983
2022-03-03 Robertson Michelle (EVP, CHIEF FINANCIAL OFFICER) Sale 767 17.33 13,290
2022-02-08 Eaton Bruce (EVP, CHIEF BUSINESS OFFICER) Sale 302 17.63 5,323
2022-01-11 Robertson Michelle (Chief Financial Officer) Sale 1,744 25.70 44,820
2022-01-03 Mullen James C (CEO) Sale 36,504 26.95 983,964
2021-11-12 Michaels Lisa Anne (EVP/Chief Medical Officer) Sale 1,568 38.33 60,101
2021-11-09 Eaton Bruce (EVP, Chief Business Officer) Sale 287 40.61 11,655
2021-10-18 Mullen James C (CEO) Sale 13,805 38.03 525,031
2021-08-09 Eaton Bruce (EVP, CHIEF BUSINESS OFFICER) Sale 287 57.17 16,407
2021-08-09 Robertson Michelle (Chief Financial Officer) Sale 2,500 60.00 150,000
2021-08-09 Robertson Michelle (Chief Financial Officer) Option Ex 2,500 30.65 76,625
2021-03-03 Hopfield Jessica Buy 5,800 45.51 263,969
2021-03-02 Mullen James C (CEO) Buy 25,000 46.27 1,156,800
2021-02-09 Collins Cynthia (CEO) Sale 1,262 66.65 84,112
2021-01-12 Robertson Michelle (Chief Financial Officer) Sale 1,568 78.27 122,727
2020-12-15 Albright Charles (EVP/Chief Scientific Officer) Sale 10,000 63.66 636,570
2020-12-15 Albright Charles (EVP/Chief Scientific Officer) Option Ex 10,000 16.51 165,100
2020-12-09 Albright Charles (EVP/Chief Scientific Officer) Sale 10,000 45.00 450,000
2020-12-09 Albright Charles (EVP/Chief Scientific Officer) Option Ex 10,000 16.51 165,100
2020-12-07 Albright Charles (EVP/Chief Scientific Officer) Sale 20,000 40.02 800,400
2020-12-07 Albright Charles (EVP/Chief Scientific Officer) Option Ex 20,000 16.51 330,200
2020-11-09 Albright Charles (EVP/Chief Scientific Officer) Sale 228 31.21 7,115
2020-10-15 Albright Charles (EVP/Chief Scientific Officer) Sale 3,000 31.39 94,170
2020-08-20 Collins Cynthia (CEO) Sale 1,976 36.66 72,440
2020-08-17 Albright Charles (EVP/Chief Scientific Officer) Sale 10,000 35.29 352,900
2020-08-17 Albright Charles (EVP/Chief Scientific Officer) Option Ex 10,000 16.51 165,100
2020-08-07 Albright Charles (EVP/Chief Scientific Officer) Sale 238 34.99 8,327
2020-08-06 Albright Charles (EVP/Chief Scientific Officer) Sale 10,000 37.47 374,700
2020-08-06 Albright Charles (EVP/Chief Scientific Officer) Option Ex 10,000 16.51 165,100
2020-07-15 Albright Charles (EVP/Chief Scientific Officer) Sale 3,000 32.22 96,660
2020-05-06 Albright Charles (EVP/Chief Scientific Officer) Sale 151 25.28 3,817
2020-02-07 Albright Charles (Chief Scientific Officer) Sale 622 26.95 16,762
2020-02-03 Albright Charles (Chief Scientific Officer) Sale 5,549 26.54 147,287
2020-01-31 Albright Charles (Chief Scientific Officer) Option Ex 17,977 .00 0
2019-08-19 Collins Cynthia (CEO) Sale 5,193 25.83 134,135
2019-03-18 Myer Vickesh (Chief Technology Officer) Sale 3,000 24.50 73,500
2019-03-18 Myer Vickesh (Chief Technology Officer) Option Ex 3,000 .65 1,950
2019-03-05 Hopfield Jessica Buy 10,200 23.94 244,188
2019-02-20 Myer Vickesh (Chief Technology Officer) Sale 3,000 20.42 61,260
2019-02-20 Myer Vickesh (Chief Technology Officer) Option Ex 3,000 .65 1,950
2019-02-04 Hack Andrew A. F. (Chief Financial Officer) Sale 6,895 21.39 147,484
2019-02-04 Hack Andrew A. F. (Chief Financial Officer) Option Ex 6,895 6.48 44,679
2019-01-18 Myer Vickesh (Chief Technology Officer) Sale 4,000 26.50 106,000
2019-01-18 Myer Vickesh (Chief Technology Officer) Option Ex 4,000 11.21 44,840
2019-01-17 Myer Vickesh (Chief Technology Officer) Sale 3,000 26.18 78,540
2019-01-17 Myer Vickesh (Chief Technology Officer) Option Ex 3,000 .65 1,950
2019-01-08 Bosley Katrine (President and CEO) Sale 12,000 25.27 303,240
2019-01-04 Hack Andrew A. F. (Chief Financial Officer) Sale 7,000 22.48 157,360
2019-01-04 Hack Andrew A. F. (Chief Financial Officer) Option Ex 7,000 6.48 45,360
2018-12-18 Myer Vickesh (Chief Technology Officer) Sale 4,000 27.41 109,640
2018-12-18 Myer Vickesh (Chief Technology Officer) Option Ex 4,000 11.21 44,840
2018-12-17 Myer Vickesh (Chief Technology Officer) Sale 3,000 28.05 84,135
2018-12-17 Myer Vickesh (Chief Technology Officer) Option Ex 3,000 .65 1,950
2018-12-03 Bosley Katrine (President and CEO) Sale 12,000 32.16 385,860
2018-11-23 Hack Andrew A. F. (Chief Financial Officer) Sale 5,284 28.38 149,933
2018-11-23 Hack Andrew A. F. (Chief Financial Officer) Option Ex 5,284 6.48 34,240
2018-11-20 Myer Vickesh (Chief Technology Officer) Sale 4,000 26.50 106,000
2018-11-20 Myer Vickesh (Chief Technology Officer) Option Ex 4,000 11.21 44,840
2018-11-19 Myer Vickesh (Chief Technology Officer) Sale 3,000 28.48 85,455
2018-11-19 Myer Vickesh (Chief Technology Officer) Option Ex 3,000 .65 1,950
2018-11-01 Bosley Katrine (President and CEO) Sale 12,000 26.62 319,440
2018-10-26 Hack Andrew A. F. (Chief Financial Officer) Sale 6,000 25.70 154,200
2018-10-26 Hack Andrew A. F. (Chief Financial Officer) Option Ex 6,000 6.48 38,880
2018-10-18 Myer Vickesh (Chief Technology Officer) Sale 4,000 29.44 117,760
2018-10-18 Myer Vickesh (Chief Technology Officer) Option Ex 4,000 11.21 44,840
2018-10-17 Myer Vickesh (Chief Technology Officer) Sale 3,000 28.87 86,610
2018-10-17 Myer Vickesh (Chief Technology Officer) Option Ex 3,000 .65 1,950
2018-10-01 Bosley Katrine (President and CEO) Sale 12,000 31.04 372,480
2018-09-28 Hack Andrew A. F. (Chief Financial Officer) Sale 8,000 32.08 256,640
2018-09-28 Hack Andrew A. F. (Chief Financial Officer) Option Ex 8,000 6.48 51,840
2018-09-18 Myer Vickesh (Chief Technology Officer) Sale 4,000 32.19 128,759
2018-09-18 Myer Vickesh (Chief Technology Officer) Option Ex 4,000 11.21 44,840
2018-09-17 Myer Vickesh (Chief Technology Officer) Sale 3,000 32.33 96,990
2018-09-17 Myer Vickesh (Chief Technology Officer) Option Ex 3,000 .65 1,950
2018-09-04 Bosley Katrine (President and CEO) Sale 12,000 32.67 392,040
2018-08-31 Hack Andrew A. F. (Chief Financial Officer) Sale 10,000 32.23 322,299
2018-08-31 Hack Andrew A. F. (Chief Financial Officer) Option Ex 10,000 6.48 64,800
2018-08-20 Myer Vickesh (Chief Technology Officer) Sale 4,000 30.11 120,440
2018-08-20 Myer Vickesh (Chief Technology Officer) Option Ex 4,000 11.21 44,840
2018-08-20 Bosley Katrine (President and CEO) Sale 12,000 30.19 362,280
2018-08-17 Myer Vickesh (Chief Technology Officer) Sale 3,000 29.65 88,950
2018-08-17 Myer Vickesh (Chief Technology Officer) Option Ex 3,000 .65 1,950
2018-08-01 Bosley Katrine (President and CEO) Sale 8,333 29.74 247,823
2018-07-18 Myer Vickesh (Chief Technology Officer) Sale 7,000 35.85 250,984
2018-07-18 Myer Vickesh (Chief Technology Officer) Option Ex 7,000 11.21 78,470
2018-07-17 Myer Vickesh (Chief Technology Officer) Sale 7,000 35.58 249,060
2018-07-17 Myer Vickesh (Chief Technology Officer) Option Ex 7,000 .65 4,550
2018-07-02 Bosley Katrine (President and CEO) Sale 8,333 36.23 301,904
2018-06-19 Myer Vickesh (Chief Technology Officer) Sale 7,000 38.39 268,730
2018-06-19 Myer Vickesh (Chief Technology Officer) Option Ex 7,000 11.21 78,470
2018-06-18 Myer Vickesh (Chief Technology Officer) Sale 7,000 38.23 267,610
2018-06-18 Myer Vickesh (Chief Technology Officer) Option Ex 7,000 .65 4,550
2018-06-13 Albright Charles (Chief Scientific Officer) Sale 10,000 35.98 359,799
2018-06-13 Albright Charles (Chief Scientific Officer) Option Ex 10,000 16.51 165,100
2018-06-04 Hack Andrew A. F. (Chief Financial Officer) Sale 3,000 37.10 111,300
2018-06-04 Hack Andrew A. F. (Chief Financial Officer) Option Ex 3,000 24.60 73,800
2018-06-01 Hack Andrew A. F. (Chief Financial Officer) Sale 7,000 39.45 276,185
2018-06-01 Hack Andrew A. F. (Chief Financial Officer) Option Ex 7,000 6.48 45,360
2018-06-01 Bosley Katrine (President and CEO) Sale 8,333 38.52 321,028
2018-05-23 Albright Charles (Chief Scientific Officer) Sale 10,000 35.00 350,000
2018-05-23 Albright Charles (Chief Scientific Officer) Option Ex 10,000 16.51 165,100
2018-05-18 Mullen James C Buy 10,000 38.02 380,250
2018-05-17 Hopfield Jessica Buy 6,700 37.28 249,782
2018-05-01 Bosley Katrine (President and CEO) Sale 8,333 31.95 266,239
2018-04-02 Bosley Katrine (President and CEO) Sale 8,333 32.22 268,489
2018-03-20 Hack Andrew A. F. (Chief Financial Officer) Sale 28,000 37.94 1,062,236
2018-03-20 Hack Andrew A. F. (Chief Financial Officer) Option Ex 28,000 12.52 350,560
2018-03-19 Hack Andrew A. F. (Chief Financial Officer) Sale 6,000 37.65 225,900
2018-03-19 Hack Andrew A. F. (Chief Financial Officer) Option Ex 6,000 6.48 38,880
2018-03-16 Hack Andrew A. F. (Chief Financial Officer) Sale 6,000 39.43 236,580
2018-03-16 Hack Andrew A. F. (Chief Financial Officer) Option Ex 6,000 6.48 38,880
2018-03-09 Bosley Katrine (President and CEO) Sale 9,134 45.00 411,030
2018-03-01 Bosley Katrine (President and CEO) Sale 8,333 35.63 296,904
2018-02-16 Hack Andrew A. F. (Chief Financial Officer) Sale 6,000 35.32 211,920
2018-02-16 Hack Andrew A. F. (Chief Financial Officer) Option Ex 6,000 6.48 38,880
2018-02-15 Hack Andrew A. F. (Chief Financial Officer) Sale 6,000 34.61 207,660
2018-02-15 Hack Andrew A. F. (Chief Financial Officer) Option Ex 6,000 6.48 38,880
2018-02-14 Hack Andrew A. F. (Chief Financial Officer) Sale 6,000 32.71 196,260
2018-02-14 Hack Andrew A. F. (Chief Financial Officer) Option Ex 6,000 6.48 38,880
2018-02-01 Bosley Katrine (President and CEO) Sale 8,333 36.70 305,837
2018-01-30 Bosley Katrine (President and CEO) Sale 10,000 40.05 400,520
2018-01-29 Bosley Katrine (President and CEO) Sale 10,000 37.53 375,340
2018-01-23 Bosley Katrine (President and CEO) Sale 3,338 35.28 117,764
2018-01-03 Bosley Katrine (President and CEO) Sale 6,662 35.04 233,416
2018-01-02 Bosley Katrine (President and CEO) Sale 8,333 32.78 273,147
2017-12-19 Hack Andrew A. F. (Chief Financial Officer) Sale 4,649 25.06 116,508
2017-12-19 Hack Andrew A. F. (Chief Financial Officer) Option Ex 4,649 3.23 15,016
2017-12-18 Hack Andrew A. F. (Chief Financial Officer) Sale 5,000 24.68 123,410
2017-12-18 Hack Andrew A. F. (Chief Financial Officer) Option Ex 5,000 3.23 16,150
2017-12-15 Hack Andrew A. F. (Chief Financial Officer) Sale 5,000 24.31 121,545
2017-12-15 Hack Andrew A. F. (Chief Financial Officer) Option Ex 5,000 3.23 16,150
2017-12-01 Bosley Katrine (President and CEO) Sale 8,333 29.50 245,790
2017-11-20 Hack Andrew A. F. (Chief Financial Officer) Sale 5,000 25.35 126,730
2017-11-20 Hack Andrew A. F. (Chief Financial Officer) Option Ex 5,000 3.23 16,150
2017-11-17 Hack Andrew A. F. (Chief Financial Officer) Sale 5,000 24.82 124,075
2017-11-17 Hack Andrew A. F. (Chief Financial Officer) Option Ex 5,000 3.23 16,150
2017-11-01 Bosley Katrine (President and CEO) Sale 8,333 24.22 201,858
2017-10-02 Bosley Katrine (President and CEO) Sale 8,333 25.05 208,741
2017-09-05 Bosley Katrine (President and CEO) Sale 6,666 20.20 134,679
2017-09-01 Bosley Katrine (President and CEO) Sale 10,000 20.80 207,970
2017-08-11 Bosley Katrine (President and CEO) Sale 6,666 20.02 133,453
2017-08-10 Bosley Katrine (President and CEO) Sale 10,000 20.02 200,159
2017-06-02 Cox Gerald Frank (Chief Medical Officer) Buy 4,000 14.15 56,600
2017-06-02 Nikolic Boris Buy 35,000 14.07 492,520
2017-05-22 Bitterman Kevin (Director) Sale 1,000,000 17.00 17,000,000
2017-03-15 Glucksmann Alexandra (Chief Operating Officer) Sale 1,000 26.41 26,410
2017-03-15 Glucksmann Alexandra (Chief Operating Officer) Option Ex 1,000 .65 650
2017-02-15 Glucksmann Alexandra (Chief Operating Officer) Sale 6,000 21.74 130,452
2017-02-15 Glucksmann Alexandra (Chief Operating Officer) Option Ex 6,000 .65 3,900
2017-02-15 Hack Andrew A. F. (Chief Financial Officer) Sale 3,000 19.20 57,600
2017-02-15 Hack Andrew A. F. (Chief Financial Officer) Option Ex 3,000 3.23 9,690
2017-01-11 Hack Andrew A. F. (Chief Financial Officer) Sale 15,000 19.20 288,000
2017-01-11 Hack Andrew A. F. (Chief Financial Officer) Option Ex 15,000 3.23 48,450
2016-12-07 Bitterman Kevin (Director) Sale 75,000 15.82 1,186,500
2016-12-07 Polaris Venture Partners Founders' Fund Vi, L.p. (10% Owner) Sale 75,000 15.82 1,186,500
2016-12-06 Bitterman Kevin (Director) Sale 50,000 15.87 793,500
2016-12-06 Polaris Venture Partners Founders' Fund Vi, L.p. (10% Owner) Sale 50,000 15.87 793,500
2016-12-05 Bitterman Kevin (Director) Sale 80,000 15.74 1,259,200
2016-12-05 Polaris Venture Partners Founders' Fund Vi, L.p. (10% Owner) Sale 80,000 15.74 1,259,200
2016-11-23 Bitterman Kevin (Director) Sale 21,480 15.71 337,450
2016-11-23 Polaris Venture Partners Founders' Fund Vi, L.p. (10% Owner) Sale 21,480 15.71 337,450
2016-11-22 Bitterman Kevin (Director) Sale 12,819 15.77 202,155
2016-11-22 Polaris Venture Partners Founders' Fund Vi, L.p. (10% Owner) Sale 12,819 15.77 202,155
2016-11-16 Bitterman Kevin (Director) Sale 30,830 16.30 502,529
2016-11-16 Polaris Venture Partners Founders' Fund Vi, L.p. (10% Owner) Sale 30,830 16.30 502,529
2016-11-15 Bitterman Kevin (Director) Sale 30,865 17.16 529,797
2016-11-15 Polaris Venture Partners Founders' Fund Vi, L.p. (10% Owner) Sale 30,865 17.16 529,797
2016-11-14 Bitterman Kevin (Director) Sale 58,035 17.16 995,880
2016-11-14 Polaris Venture Partners Founders' Fund Vi, L.p. (10% Owner) Sale 58,035 17.16 995,880
2016-09-08 Bitterman Kevin (Director) Sale 500,000 16.80 8,400,000
2016-09-08 Polaris Venture Partners Founders' Fund Vi, L.p. (10% Owner) Sale 500,000 16.80 8,400,000
2016-09-06 Starr Kevin P (10% Owner) Sale 5,890 15.90 93,668
2016-08-23 Glucksmann Alexandra (Chief Operating Officer) Sale 1,000 20.00 20,000
2016-08-23 Glucksmann Alexandra (Chief Operating Officer) Option Ex 1,000 .65 650
2016-02-08 Deerfield Mgmt Hif, L.p. Buy 100,000 16.00 1,600,000
2015-02-08 Viking Long Fund Master Ltd. Buy 2,040,814 .00 0
2015-02-08 Sundheim Daniel S. Buy 2,040,814 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises of EDIT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Editas Medicine, Inc. (symbol EDIT, CIK number 1650664) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.